Protalix BioTherapeutics
PLX
#8714
Rank
A$0.16 B
Marketcap
$2.18
Share price
13.71%
Change (1 day)
1.74%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -A$19.77 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are A$38.05 Million. In 2023 the company made an earning of A$18.2 Million, an increase over its 2022 earnings that were of -A$18.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$19.77 Million-208.55%
2023 A$18.2 M-199.05%
2022 -A$18.39 Million-40.38%
2021 -A$30.84 Million-732.31%
2020 A$4.87 M-130.53%
2019 -A$15.98 Million189.85%
2018 -A$5.52 Million-95.29%
2017 -A$0.12 Billion308.12%
2016 -A$28.68 Million-32.37%
2015 -A$42.41 Million10.11%
2014 -A$38.51 Million-7.59%
2013 -A$41.68 Million
2011 -A$48.26 Million-19.39%
2010 -A$59.87 Million20.87%
2009 -A$49.53 Million32.26%
2008 -A$37.45 Million-5.46%
2007 -A$39.61 Million
2004 -A$0.26 Million12.35%
2003 -A$0.23 Million-11.1%
2002 -A$0.26 Million-57.03%
2001 -A$0.6 Million1.03%
2000 -A$0.6 Million-53.22%
1999 -A$1.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.16 Billion 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.01 B-5,090.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.88 Billion 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.28 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel